Yi Ping Li

Yi Ping Li

Net worth: 2 M $ as of 31/05/2026

62 year
Health Technology
Finance
Consumer Services

Profile

Dr. Yi Ping Li, MD, is a Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd., a Chairman at JW Therapeutics (Shanghai) Co., Ltd. and a Chief Executive Officer & Director at JW Biotechnology (Shanghai) Co. Ltd. He is on the Board of Directors at JW (Cayman) Therapeutics Co. Ltd., JW Biotechnology (Shanghai) Co. Ltd. and GenScript Corp.
Dr. Li was previously employed as a General Manager by Amgen Biotechnology Consulting Shanghai Co., Ltd., a Partner by Kleiner Perkins Caufield & Byers LLC, a Medical Director by Merck Serono SA, and a Partner by KPCB (China) Advisory Co. Ltd. He also served on the board at China Kanghui Holdings.
He received his graduate degree from The University of Montana and a doctorate degree from Shanghai Jiao Tong University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
07/07/2025 9,206,460 ( 2.21% ) 2 M $ 31/05/2026

Yi Ping Li active positions

CompaniesPositionStart
JW (CAYMAN) THERAPEUTICS CO. LTD Founder 06/09/2017
Director/Board Member 27/07/2010
JW Biotechnology (Shanghai) Co. Ltd.
Founder -
Founder 01/02/2016

Former positions of Yi Ping Li

CompaniesPositionEnd
Amgen Biotechnology Consulting Shanghai Co., Ltd.
Chief Executive Officer 01/07/2015
Director/Board Member 08/11/2010
Corporate Officer/Principal 30/08/2006
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Yi Ping Li's experience

Training of Yi Ping Li

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Consumer Services

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

JW Biotechnology (Shanghai) Co. Ltd.

Health Technology

Health Technology

Amgen Biotechnology Consulting Shanghai Co., Ltd.

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!